Observational studyInternational journal of clinical oncology2020

Therapeutic drug monitoring of regorafenib and its metabolite M5 can predict treatment efficacy and the occurrence of skin toxicities.

Daiki Taguchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.